FLUOROURACIL , OXALIPLATIN , IRINOTECAN, GEMCITABINE , CAPECITABINE , CALCIUM FOLINATE clinical trials

An open labelled phase III adjuvant trial of disease-free survival in patients with resected pancreatic ductal adenocarcinoma randomized to allocation of oxaliplatin- or gemcitabine-based chemotherapy by standard clinical criteria or by a transcriptomic treatment specific stratification signature (ESPAC-6)

This study is looking at different chemotherapy treatments for people in the UK who have had pancreatic cancer removed by surgery. It aims to find out which treatment works best to stop the cancer from coming back by comparing standard care with a new way of choosing treatment based on genetic information.